The new president of Impax Laboratories Inc.’s generic drug business will be paid a base salary of $470,000, plus a one-time $75,000 hiring bonus, and work out of company offices in suburban Philadelphia.
Carole Ben-Maimon, who the Hayward-based company (NASDAQ: IPXL) said in September it had hired to run its global pharmaceuticals division, also can participate in Impax’s management bonus program and received an option to buy 75,000 shares of common stock and 24,000 shares of restricted stock, according to a Securities and Exchange Commission filing Wednesday.
No comments:
Post a Comment